We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
1276
Precigen
PGEN
$1.99B
$1K ﹤0.01%
708
PMVP icon
1277
PMV Pharmaceuticals
PMVP
$62.9M
$1K ﹤0.01%
132
QSI icon
1278
Quantum-Si Incorporated
QSI
$168M
$1K ﹤0.01%
343
RPTX
1279
DELISTED
Repare Therapeutics
RPTX
$1K ﹤0.01%
127
SGMO
1280
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1K ﹤0.01%
498
SIGA icon
1281
SIGA Technologies
SIGA
$227M
$1K ﹤0.01%
270
STOK icon
1282
Stoke Therapeutics
STOK
$1.83B
$1K ﹤0.01%
126
STRO icon
1283
Sutro Biopharma
STRO
$388M
$1K ﹤0.01%
16
TERN
1284
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
TNGX icon
1285
Tango Therapeutics
TNGX
$4.33B
$1K ﹤0.01%
355
VIG icon
1286
Vanguard Dividend Appreciation ETF
VIG
$111B
0
VNDA icon
1287
Vanda Pharmaceuticals
VNDA
$316M
$1K ﹤0.01%
191
VUG icon
1288
Vanguard Growth ETF
VUG
$216B
0
WVE icon
1289
Wave Life Sciences
WVE
$1.14B
$1K ﹤0.01%
349
XERS icon
1290
Xeris Biopharma Holdings
XERS
$1.44B
$1K ﹤0.01%
404
KLRS
1291
Kalaris Therapeutics
KLRS
$84.7M
$1K ﹤0.01%
16
OMGA
1292
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1K ﹤0.01%
139
PSTX
1293
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
346
EGRX
1294
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
ALPN
1295
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
85
MRNS
1296
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58
NGM
1297
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1K ﹤0.01%
265
GRCL
1298
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$1K ﹤0.01%
146
NSTG
1299
DELISTED
NanoString Technologies, Inc.
NSTG
$1K ﹤0.01%
156
ABSI icon
1300
Absci
ABSI
$1.3B
$0 ﹤0.01%
270

Similar funds

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.